CD19/CD20 Dual-CAR-T cells

BIOLOGICAL3 trials

Sponsors

Hebei Yanda Ludaopei Hospital, Beijing Tsinghua Chang Gung Hospital

Conditions

B-cell LeukemiaB-cell LymphomaB-cell Non-Hodgkin's Lymphoma

Early Phase 1

CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.

SuspendedNCT04697290

Beijing Tsinghua Chang Gung HospitalB-cell Non-Hodgkin's Lymphoma

Start: 2022-03-10End: 2023-06-10Target: 12Updated: 2022-02-14

Phase 1

CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients

CompletedNCT04260945

Hebei Yanda Ludaopei HospitalB-cell Leukemia

Start: 2020-03-10End: 2022-02-10Updated: 2022-03-08

CD19/CD20 Dual-CAR-T in B-cell Lymphoma Patients

CompletedNCT04260932

Hebei Yanda Ludaopei HospitalB-cell Lymphoma

Start: 2020-03-01End: 2021-09-10Updated: 2022-03-08